A Mini-review on the Significance of Benzimidazole in Antifungal Drug Design: Past Insights and Current Applications

Benzimidazole and its derivatives have been extensively investigated for their antifungal activity, playing a crucial role in drug development. Initially, known for their agricultural applications, these compounds have evolved into significant therapeutic agents in medical mycology. The antifungal activity of benzimidazole was first identified in fungicides used in agriculture, especially for the management of fungal diseases in crops. Over time, its mode of action, mainly acting on fungal microtubules, led to its application in veterinary and human medicine. Early preclinical studies demonstrated effectiveness against dermatophytes and systemic fungal infections, paving the way for further research. Modern benzimidazole derivatives have been structurally modified to improve their antifungal activity, bioavailability, and safety profile. These compounds are now used to treat fungal infections in both clinical and agricultural applications. However, challenges, such as resistance development and toxicity concerns, have made it imperative to continue research to maximize their therapeutic value. Benzimidazole remains a cornerstone in antifungal drug development, and its earlier and current applications reinforce its relevance. Medicinal chemistry and pharmacology must move forward to overcome the limitations and expand their clinical utility. This review analyzes past discoveries and current advancements, offering insight into the future trajectory of benzimidazole-based antifungal therapy.